This study was conceived to provide current information on the already identified MODY genes with their mechanism of actions and phenotypic presentations.
Read More
This review explores the recommended guidelines on combination therapy with SAC/VAL, advantages and disadvantages of this combination over traditional therapies, and effectiveness and safety of SAC/VAL in patients with HFrEF. Additionally, this review also scrutinizes the cost-effectiveness of SAC/VAL to understand the clinical utility this drug, specifically in developing parts of the world.
Read More The review summarizes the outline on the categorization, use, safety, effectiveness for smoking cessation and regulatory issues of the electronic cigarette.
Read More
SOURCE. www.cdc.gov Authors. Shikha Garg, MD1,*; Lindsay Kim, MD1,*; Michael Whitaker, MPH1,2; Alissa O’Halloran, MSPH1; Charisse Cummings, MPH1,3; Rachel Holstein, MPH1,4; […]
Read More This review addresses the magnitude of the problem of diabetes, prevalence and cardiovascular complications of DM in the Gulf Cooperation Council (GCC) countries. Further, the review also highlights the causes, guideline implications, and prevention measures for DM control in the GCC countries.
Read More The current review aims to highlight the role of frailty in patient selection for TAVR, prognostication, and tailoring post-operative care to enhance quality of life.
Read More
We aimed to find the association between baseline coronary patency & culprit site with PCI outcome and the incidence of major adverse cardiac events (MACE).
Read More
The aim of this study is to investigate the association of CHA2DS2-VASc-HSF score with severity of Coronary Artery Disease as assessed by Syntax Score (SxS) in patients with Non ST Segment Elevation Myocardial Infarction.
Read More
Evidence-based practice (EBP) is an integral part of stroke rehabilitation, to achieve optimal results by practicing best evidence available in the literature. A survey was conducted to find the knowledge of EBP and preferred treatment used by the physiotherapists in Saudi Arabia for stroke rehabilitation.
Read More Cancer therapies can affect the whole cardiovascular system, but these cardiotoxic effects are generally reported as changes in left ventricular (LV) ejection fraction. The most common cardiovascular adverse effects are LV dysfunction and heart failure (HF). Other adverse effects include hypertension, acute coronary syndromes, thromboembolic events, rhythm disturbances, and valvular and/or pericardial disease. Hence, prediction, early recognition, and timely management of cardiovascular complications in patients with cancer are gaining importance. This need gave birth to the concept of interdisciplinary cardiology-oncology (cardio-oncology) care delivered through teams of cardiologists, oncologists, and hematologists.
Read More